Active Pharmaceutical Ingredients - Global Market Outlook (2017-2026)
According to Stratistics MRC, the Global Active Pharmaceutical Ingredients Market is accounted for $151.89 billion in 2017 and is expected to reach $308.48 billion by 2026 growing at a CAGR of 8.2% from 2017 to 2026. Increase in incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals are some factors fueling the market growth. However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries are restricting the market growth.
Active pharmaceutical ingredients are any substance or combination of substances used in a finished pharmaceutical product with pharmacological activity. Active Pharmaceutical Ingredients are chemically and biologically active components of drugs with direct effect in cure, mitigation, treatment and prevention of diseases. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
Amongst Customer Base, Generic segment accounted for significant market share during the forecast period. Generic drugs benefit from the patent expiration of innovative drug as it makes them readily available in the market. The demand to produce quality medicines at lower and affordable costs creates a scenario, where the needs for generic drugs increase. By geography, Asia Pacific dominated the market due to the rising healthcare spending which has led to quality healthcare becoming accessible along with a higher demand for pharmaceutical products across APAC. The pharmaceuticals consumed here are mostly produced in onshore manufacturing units. Furthermore, contract manufacturing organizations are key outsourcing allies for pharmaceutical companies that supply their wares across the region.
Some of the key players in Active Pharmaceutical Ingredients market include Teva Active Pharmaceutical Industries Limited, Ranbaxy Laboratories, Pfizer, Inc, Novartis, Mylan N.V, Lupin, Dr. Reddy's Lab, Boehringer Ingelheim GmbH, Aurobindo pharma, Albemarle Corporation, Ceva Animal Health, Inc., Virbac, Sun Pharmaceutical Industries Ltd., Merck Animal Health (U.S.), Elanco Animal Health (U.S.), Zoetis (U.S.), Merial Inc. (Sanofi) (France), Bioniche Animal Health (Canada), Bayer Healthcare (Germany), ELI Lilly and Company, Glaxosmithkline PLC, Abbvie Inc., Sanofi and Bristol-Myers Squibb.
Drug Types Covered:
Active pharmaceutical ingredients are any substance or combination of substances used in a finished pharmaceutical product with pharmacological activity. Active Pharmaceutical Ingredients are chemically and biologically active components of drugs with direct effect in cure, mitigation, treatment and prevention of diseases. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
Amongst Customer Base, Generic segment accounted for significant market share during the forecast period. Generic drugs benefit from the patent expiration of innovative drug as it makes them readily available in the market. The demand to produce quality medicines at lower and affordable costs creates a scenario, where the needs for generic drugs increase. By geography, Asia Pacific dominated the market due to the rising healthcare spending which has led to quality healthcare becoming accessible along with a higher demand for pharmaceutical products across APAC. The pharmaceuticals consumed here are mostly produced in onshore manufacturing units. Furthermore, contract manufacturing organizations are key outsourcing allies for pharmaceutical companies that supply their wares across the region.
Some of the key players in Active Pharmaceutical Ingredients market include Teva Active Pharmaceutical Industries Limited, Ranbaxy Laboratories, Pfizer, Inc, Novartis, Mylan N.V, Lupin, Dr. Reddy's Lab, Boehringer Ingelheim GmbH, Aurobindo pharma, Albemarle Corporation, Ceva Animal Health, Inc., Virbac, Sun Pharmaceutical Industries Ltd., Merck Animal Health (U.S.), Elanco Animal Health (U.S.), Zoetis (U.S.), Merial Inc. (Sanofi) (France), Bioniche Animal Health (Canada), Bayer Healthcare (Germany), ELI Lilly and Company, Glaxosmithkline PLC, Abbvie Inc., Sanofi and Bristol-Myers Squibb.
Drug Types Covered:
- Generic Prescription
- Innovative Drugs
- Over-the-counter (OTC) Drugs
- Prescription Drugs
- Potency
- Innovative API
- Generic API
- Contract Manufacturers
- Captive Manufacturers
- Merchant API Manufacturers
- Biotech Active Pharmaceutical Ingredients
- Synthetic Active Pharmaceutical Ingredients
- Biological API
- Chemical API
- Large Molecule
- Small Molecule
- Anti-diabetic Drugs
- Cardiovascular Disease
- Central Nervous System and Neurological Disorders
- Diabetes
- Endocrinology
- Gastrointestinal Disorders
- Musculoskeletal drugs
- Non-steroidal Anti-inflammatory Drugs
- Oncology
- Orthopedic Disorders
- Respiratory
- Urology
- Other Applications
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY DRUG TYPE
5.1 Introduction
5.2 Generic Prescription
5.3 Innovative Drugs
5.4 Over-the-counter (OTC) Drugs
5.5 Prescription Drugs
5.6 Potency
5.6.1 Low to Moderate Potency
5.6.2 Potent to Highly Potent
6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY API FORMULATION
6.1 Introduction
6.2 Innovative API
6.3 Generic API
7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER
7.1 Introduction
7.2 Contract Manufacturers
7.3 Captive Manufacturers
7.4 Merchant API Manufacturers
7.4.1 Generic Merchant API Manufacturers
7.4.2 Innovative Merchant API Manufacturers
8 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS
8.1 Introduction
8.2 Biotech Active Pharmaceutical Ingredients
8.2.1 Type
8.2.1.1 Biosimilars
8.2.1.2 Innovative Biotech APIs
8.2.2 Expression System
8.2.2.1 Insect Expression Systems
8.2.2.2 Mammalian Expression Systems
8.2.2.3 Microbial Expression Systems
8.2.2.4 Plant Expression Systems
8.2.2.5 Yeast Expression Systems
8.2.3 Product
8.2.3.1 Blood Factors
8.2.3.2 Cytokines
8.2.3.3 Fusion Proteins
8.2.3.4 Hormones and Growth Factors
8.2.3.5 Monoclonal Antibodies
8.2.3.6 Therapeutic Enzymes
8.2.3.7 Vaccines
8.3 Synthetic Active Pharmaceutical Ingredients
8.3.1 Generic Synthetic APIs
8.3.2 Innovative Synthetic APIs
9 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY API TYPE
9.1 Introduction
9.2 Biological API
9.3 Chemical API
10 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY MOLECULE
10.1 Introduction
10.2 Large Molecule
10.3 Small Molecule
11 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY APPLICATION
11.1 Introduction
11.2 Anti-diabetic Drugs
11.3 Cardiovascular Disease
11.4 Central Nervous System and Neurological Disorders
11.5 Diabetes
11.6 Endocrinology
11.7 Gastrointestinal Disorders
11.8 Musculoskeletal drugs
11.9 Non-steroidal Anti-inflammatory Drugs
11.10 Oncology
11.11 Orthopedic Disorders
11.12 Respiratory
11.13 Urology
11.14 Other Applications
12 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY GEOGRAPHY
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa
13 KEY DEVELOPMENTS
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies
14 COMPANY PROFILING
14.1 Teva Active Pharmaceutical Industries Limited
14.2 Ranbaxy Laboratories
14.3 Pfizer, Inc
14.4 Novartis
14.5 Mylan N.V
14.6 Lupin
14.7 Dr. Reddy's Lab
14.8 Boehringer Ingelheim GmbH
14.9 Aurobindo pharma
14.10 Albemarle Corporation
14.11 Ceva Animal Health, Inc.
14.12 Virbac
14.13 Sun Pharmaceutical Industries Ltd.
14.14 Merck Animal Health (U.S.)
14.15 Elanco Animal Health (U.S.)
14.16 Zoetis (U.S.)
14.17 Merial Inc. (Sanofi) (France)
14.18 Bioniche Animal Health (Canada)
14.19 Bayer Healthcare (Germany)
14.20 ELI Lilly and Company
14.21 Glaxosmithkline PLC
14.22 Abbvie Inc.
14.23 Sanofi
14.24 Bristol-Myers Squibb
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY DRUG TYPE
5.1 Introduction
5.2 Generic Prescription
5.3 Innovative Drugs
5.4 Over-the-counter (OTC) Drugs
5.5 Prescription Drugs
5.6 Potency
5.6.1 Low to Moderate Potency
5.6.2 Potent to Highly Potent
6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY API FORMULATION
6.1 Introduction
6.2 Innovative API
6.3 Generic API
7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER
7.1 Introduction
7.2 Contract Manufacturers
7.3 Captive Manufacturers
7.4 Merchant API Manufacturers
7.4.1 Generic Merchant API Manufacturers
7.4.2 Innovative Merchant API Manufacturers
8 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS
8.1 Introduction
8.2 Biotech Active Pharmaceutical Ingredients
8.2.1 Type
8.2.1.1 Biosimilars
8.2.1.2 Innovative Biotech APIs
8.2.2 Expression System
8.2.2.1 Insect Expression Systems
8.2.2.2 Mammalian Expression Systems
8.2.2.3 Microbial Expression Systems
8.2.2.4 Plant Expression Systems
8.2.2.5 Yeast Expression Systems
8.2.3 Product
8.2.3.1 Blood Factors
8.2.3.2 Cytokines
8.2.3.3 Fusion Proteins
8.2.3.4 Hormones and Growth Factors
8.2.3.5 Monoclonal Antibodies
8.2.3.6 Therapeutic Enzymes
8.2.3.7 Vaccines
8.3 Synthetic Active Pharmaceutical Ingredients
8.3.1 Generic Synthetic APIs
8.3.2 Innovative Synthetic APIs
9 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY API TYPE
9.1 Introduction
9.2 Biological API
9.3 Chemical API
10 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY MOLECULE
10.1 Introduction
10.2 Large Molecule
10.3 Small Molecule
11 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY APPLICATION
11.1 Introduction
11.2 Anti-diabetic Drugs
11.3 Cardiovascular Disease
11.4 Central Nervous System and Neurological Disorders
11.5 Diabetes
11.6 Endocrinology
11.7 Gastrointestinal Disorders
11.8 Musculoskeletal drugs
11.9 Non-steroidal Anti-inflammatory Drugs
11.10 Oncology
11.11 Orthopedic Disorders
11.12 Respiratory
11.13 Urology
11.14 Other Applications
12 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY GEOGRAPHY
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa
13 KEY DEVELOPMENTS
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies
14 COMPANY PROFILING
14.1 Teva Active Pharmaceutical Industries Limited
14.2 Ranbaxy Laboratories
14.3 Pfizer, Inc
14.4 Novartis
14.5 Mylan N.V
14.6 Lupin
14.7 Dr. Reddy's Lab
14.8 Boehringer Ingelheim GmbH
14.9 Aurobindo pharma
14.10 Albemarle Corporation
14.11 Ceva Animal Health, Inc.
14.12 Virbac
14.13 Sun Pharmaceutical Industries Ltd.
14.14 Merck Animal Health (U.S.)
14.15 Elanco Animal Health (U.S.)
14.16 Zoetis (U.S.)
14.17 Merial Inc. (Sanofi) (France)
14.18 Bioniche Animal Health (Canada)
14.19 Bayer Healthcare (Germany)
14.20 ELI Lilly and Company
14.21 Glaxosmithkline PLC
14.22 Abbvie Inc.
14.23 Sanofi
14.24 Bristol-Myers Squibb
LIST OF TABLES
Table 1 Global Active Pharmaceutical Ingredients Market Outlook, By Region (2016-2026) (US $MN)
Table 2 Global Active Pharmaceutical Ingredients Market Outlook, By Drug Type (2016-2026) (US $MN)
Table 3 Global Active Pharmaceutical Ingredients Market Outlook, By Generic Prescription (2016-2026) (US $MN)
Table 4 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative Drugs (2016-2026) (US $MN)
Table 5 Global Active Pharmaceutical Ingredients Market Outlook, By Over-the-counter (OTC) Drugs (2016-2026) (US $MN)
Table 6 Global Active Pharmaceutical Ingredients Market Outlook, By Prescription Drugs (2016-2026) (US $MN)
Table 7 Global Active Pharmaceutical Ingredients Market Outlook, By Potency (2016-2026) (US $MN)
Table 8 Global Active Pharmaceutical Ingredients Market Outlook, By Low to Moderate Potency (2016-2026) (US $MN)
Table 9 Global Active Pharmaceutical Ingredients Market Outlook, By Potent to Highly Potent (2016-2026) (US $MN)
Table 10 Global Active Pharmaceutical Ingredients Market Outlook, By API Formulation (2016-2026) (US $MN)
Table 11 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative API (2016-2026) (US $MN)
Table 12 Global Active Pharmaceutical Ingredients Market Outlook, By Generic API (2016-2026) (US $MN)
Table 13 Global Active Pharmaceutical Ingredients Market Outlook, By Type of Manufacturer (2016-2026) (US $MN)
Table 14 Global Active Pharmaceutical Ingredients Market Outlook, By Contract Manufacturers (2016-2026) (US $MN)
Table 15 Global Active Pharmaceutical Ingredients Market Outlook, By Captive Manufacturers (2016-2026) (US $MN)
Table 16 Global Active Pharmaceutical Ingredients Market Outlook, By Merchant API Manufacturers (2016-2026) (US $MN)
Table 17 Global Active Pharmaceutical Ingredients Market Outlook, By Generic Merchant API Manufacturers (2016-2026) (US $MN)
Table 18 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative Merchant API Manufacturers (2016-2026) (US $MN)
Table 19 Global Active Pharmaceutical Ingredients Market Outlook, By Type of Synthesis (2016-2026) (US $MN)
Table 20 Global Active Pharmaceutical Ingredients Market Outlook, By Biotech Active Pharmaceutical Ingredients (2016-2026) (US $MN)
Table 21 Global Active Pharmaceutical Ingredients Market Outlook, By Type (2016-2026) (US $MN)
Table 22 Global Active Pharmaceutical Ingredients Market Outlook, By Expression System (2016-2026) (US $MN)
Table 23 Global Active Pharmaceutical Ingredients Market Outlook, By Product (2016-2026) (US $MN)
Table 24 Global Active Pharmaceutical Ingredients Market Outlook, By Synthetic Active Pharmaceutical Ingredients (2016-2026) (US $MN)
Table 25 Global Active Pharmaceutical Ingredients Market Outlook, By Generic Synthetic APIs (2016-2026) (US $MN)
Table 26 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative Synthetic APIs (2016-2026) (US $MN)
Table 27 Global Active Pharmaceutical Ingredients Market Outlook, By API Type (2016-2026) (US $MN)
Table 28 Global Active Pharmaceutical Ingredients Market Outlook, By Biological API (2016-2026) (US $MN)
Table 29 Global Active Pharmaceutical Ingredients Market Outlook, By Chemical API (2016-2026) (US $MN)
Table 30 Global Active Pharmaceutical Ingredients Market Outlook, By Molecule (2016-2026) (US $MN)
Table 31 Global Active Pharmaceutical Ingredients Market Outlook, By Large Molecule (2016-2026) (US $MN)
Table 32 Global Active Pharmaceutical Ingredients Market Outlook, By Small Molecule (2016-2026) (US $MN)
Table 33 Global Active Pharmaceutical Ingredients Market Outlook, By Application (2016-2026) (US $MN)
Table 34 Global Active Pharmaceutical Ingredients Market Outlook, By Anti-diabetic Drugs (2016-2026) (US $MN)
Table 35 Global Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular Disease (2016-2026) (US $MN)
Table 36 Global Active Pharmaceutical Ingredients Market Outlook, By Central Nervous System and Neurological Disorders (2016-2026) (US $MN)
Table 37 Global Active Pharmaceutical Ingredients Market Outlook, By Diabetes (2016-2026) (US $MN)
Table 38 Global Active Pharmaceutical Ingredients Market Outlook, By Endocrinology (2016-2026) (US $MN)
Table 39 Global Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal Disorders (2016-2026) (US $MN)
Table 40 Global Active Pharmaceutical Ingredients Market Outlook, By Musculoskeletal drugs (2016-2026) (US $MN)
Table 41 Global Active Pharmaceutical Ingredients Market Outlook, By Non-steroidal Anti-inflammatory Drugs (2016-2026) (US $MN)
Table 42 Global Active Pharmaceutical Ingredients Market Outlook, By Oncology (2016-2026) (US $MN)
Table 43 Global Active Pharmaceutical Ingredients Market Outlook, By Orthopedic Disorders (2016-2026) (US $MN)
Table 44 Global Active Pharmaceutical Ingredients Market Outlook, By Respiratory (2016-2026) (US $MN)
Table 45 Global Active Pharmaceutical Ingredients Market Outlook, By Urology (2016-2026) (US $MN)
Table 46 Global Active Pharmaceutical Ingredients Market Outlook, By Other Applications (2016-2026) (US $MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.
Table 1 Global Active Pharmaceutical Ingredients Market Outlook, By Region (2016-2026) (US $MN)
Table 2 Global Active Pharmaceutical Ingredients Market Outlook, By Drug Type (2016-2026) (US $MN)
Table 3 Global Active Pharmaceutical Ingredients Market Outlook, By Generic Prescription (2016-2026) (US $MN)
Table 4 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative Drugs (2016-2026) (US $MN)
Table 5 Global Active Pharmaceutical Ingredients Market Outlook, By Over-the-counter (OTC) Drugs (2016-2026) (US $MN)
Table 6 Global Active Pharmaceutical Ingredients Market Outlook, By Prescription Drugs (2016-2026) (US $MN)
Table 7 Global Active Pharmaceutical Ingredients Market Outlook, By Potency (2016-2026) (US $MN)
Table 8 Global Active Pharmaceutical Ingredients Market Outlook, By Low to Moderate Potency (2016-2026) (US $MN)
Table 9 Global Active Pharmaceutical Ingredients Market Outlook, By Potent to Highly Potent (2016-2026) (US $MN)
Table 10 Global Active Pharmaceutical Ingredients Market Outlook, By API Formulation (2016-2026) (US $MN)
Table 11 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative API (2016-2026) (US $MN)
Table 12 Global Active Pharmaceutical Ingredients Market Outlook, By Generic API (2016-2026) (US $MN)
Table 13 Global Active Pharmaceutical Ingredients Market Outlook, By Type of Manufacturer (2016-2026) (US $MN)
Table 14 Global Active Pharmaceutical Ingredients Market Outlook, By Contract Manufacturers (2016-2026) (US $MN)
Table 15 Global Active Pharmaceutical Ingredients Market Outlook, By Captive Manufacturers (2016-2026) (US $MN)
Table 16 Global Active Pharmaceutical Ingredients Market Outlook, By Merchant API Manufacturers (2016-2026) (US $MN)
Table 17 Global Active Pharmaceutical Ingredients Market Outlook, By Generic Merchant API Manufacturers (2016-2026) (US $MN)
Table 18 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative Merchant API Manufacturers (2016-2026) (US $MN)
Table 19 Global Active Pharmaceutical Ingredients Market Outlook, By Type of Synthesis (2016-2026) (US $MN)
Table 20 Global Active Pharmaceutical Ingredients Market Outlook, By Biotech Active Pharmaceutical Ingredients (2016-2026) (US $MN)
Table 21 Global Active Pharmaceutical Ingredients Market Outlook, By Type (2016-2026) (US $MN)
Table 22 Global Active Pharmaceutical Ingredients Market Outlook, By Expression System (2016-2026) (US $MN)
Table 23 Global Active Pharmaceutical Ingredients Market Outlook, By Product (2016-2026) (US $MN)
Table 24 Global Active Pharmaceutical Ingredients Market Outlook, By Synthetic Active Pharmaceutical Ingredients (2016-2026) (US $MN)
Table 25 Global Active Pharmaceutical Ingredients Market Outlook, By Generic Synthetic APIs (2016-2026) (US $MN)
Table 26 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative Synthetic APIs (2016-2026) (US $MN)
Table 27 Global Active Pharmaceutical Ingredients Market Outlook, By API Type (2016-2026) (US $MN)
Table 28 Global Active Pharmaceutical Ingredients Market Outlook, By Biological API (2016-2026) (US $MN)
Table 29 Global Active Pharmaceutical Ingredients Market Outlook, By Chemical API (2016-2026) (US $MN)
Table 30 Global Active Pharmaceutical Ingredients Market Outlook, By Molecule (2016-2026) (US $MN)
Table 31 Global Active Pharmaceutical Ingredients Market Outlook, By Large Molecule (2016-2026) (US $MN)
Table 32 Global Active Pharmaceutical Ingredients Market Outlook, By Small Molecule (2016-2026) (US $MN)
Table 33 Global Active Pharmaceutical Ingredients Market Outlook, By Application (2016-2026) (US $MN)
Table 34 Global Active Pharmaceutical Ingredients Market Outlook, By Anti-diabetic Drugs (2016-2026) (US $MN)
Table 35 Global Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular Disease (2016-2026) (US $MN)
Table 36 Global Active Pharmaceutical Ingredients Market Outlook, By Central Nervous System and Neurological Disorders (2016-2026) (US $MN)
Table 37 Global Active Pharmaceutical Ingredients Market Outlook, By Diabetes (2016-2026) (US $MN)
Table 38 Global Active Pharmaceutical Ingredients Market Outlook, By Endocrinology (2016-2026) (US $MN)
Table 39 Global Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal Disorders (2016-2026) (US $MN)
Table 40 Global Active Pharmaceutical Ingredients Market Outlook, By Musculoskeletal drugs (2016-2026) (US $MN)
Table 41 Global Active Pharmaceutical Ingredients Market Outlook, By Non-steroidal Anti-inflammatory Drugs (2016-2026) (US $MN)
Table 42 Global Active Pharmaceutical Ingredients Market Outlook, By Oncology (2016-2026) (US $MN)
Table 43 Global Active Pharmaceutical Ingredients Market Outlook, By Orthopedic Disorders (2016-2026) (US $MN)
Table 44 Global Active Pharmaceutical Ingredients Market Outlook, By Respiratory (2016-2026) (US $MN)
Table 45 Global Active Pharmaceutical Ingredients Market Outlook, By Urology (2016-2026) (US $MN)
Table 46 Global Active Pharmaceutical Ingredients Market Outlook, By Other Applications (2016-2026) (US $MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.
